RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Revenue

AbbVie Inc.ABBV

Market cap
$417.4B
P/E ratio
SummaryFinancials
Period EndRevenue (Million USD)YoY (%)
Dec 31, 202456,334+3.71%
Dec 31, 202354,318-6.44%
Dec 31, 202258,054+3.30%
Dec 31, 202156,197+22.69%
Dec 31, 202045,804+37.69%
Dec 31, 201933,266+1.57%
Dec 31, 201832,753+16.08%
Dec 31, 201728,216+10.06%
Dec 31, 201625,638+12.16%
Dec 31, 201522,859+14.52%
Dec 31, 201419,960+6.23%
Dec 31, 201318,790

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)